Cargando…
Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
The measurement of procalcitonin has recently become a mainstay for the diagnosis and therapeutic management of severe bacterial infections, especially those sustained by Gram-negative bacteria. Therefore, the aim of this article is to provide a narrative overview on the potential role of procalcito...
Autores principales: | Lippi, Giuseppe, Sanchis-Gomar, Fabian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743499/ https://www.ncbi.nlm.nih.gov/pubmed/29307988 http://dx.doi.org/10.3748/wjg.v23.i47.8283 |
Ejemplares similares
-
Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing
por: Lippi, Giuseppe, et al.
Publicado: (2020) -
Red blood cell distribution width in heart failure: A narrative review
por: Lippi, Giuseppe, et al.
Publicado: (2018) -
Histopathological assessment of the microscopic activity in inflammatory bowel diseases: What are we looking for?
por: Fabian, Ondrej, et al.
Publicado: (2022) -
2523 Noninvasive biomarkers for inflammatory bowel disease: Drawbacks and potential
por: Patel, Vihang, et al.
Publicado: (2018) -
Inflammatory bowel disease and airway diseases
por: Vutcovici, Maria, et al.
Publicado: (2016)